Mona Bafadhel

Has grant

King’s College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Obstructive lung disease and the Menopause

Open Date: 2022-10-01

Close Date: 2026-09-01

Grant: Close

Inhaled steroids in COVID: The STOIC Study

Open Date: 2020-06-01

Close Date: 2023-12-01

Grant: Close

CICERO European Collaborative

Open Date: 2019-02-01

Close Date: 2025-01-01

Grant: Close

Acute exacerbations of airways disease: the AWARD study

Open Date: 2019-02-01

Close Date: 2020-02-01

Grant: Close

Inflammatory and physiological changes in COPD: the CORAL study

Open Date: 2019-01-01

Close Date: 2023-12-01

Articles (27)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (20)

John Hurst

University College London

UNITED KINGDOM

View details

Joan B Soriano

Profesor Asociado

Universidad Complutense de Madrid Facultad de Medicina

SPAIN

View details

Klaus F. Rabe

Professor of Pulmonary Medicine

Christian-Albrechts-Universität zu Kiel

GERMANY

View details

Richard Beasley

Medical Research Institute of New Zealand

NEW ZEALAND

View details

Imran Satia

McMaster University

CANADA

View details

Anne Greenough

King’s College London

UNITED KINGDOM

View details

Rocio Teresa Martinez-Nunez

King’s College London

UNITED KINGDOM

View details

Sanjay Ramakrishnan

University of Oxford

UNITED KINGDOM

View details

Charlotte Bolton

Professor of Respiratory Medicine

University of Nottingham

UNITED KINGDOM

View details

Camille Taillé

INSERM

FRANCE

View details

James Melhorn

University of Oxford

UNITED KINGDOM

View details

RICHARD RUSSELL

University of Oxford

UNITED KINGDOM

View details

Kelly Payette

King’s College London

UNITED KINGDOM

View details

Louise Donnelly

Professor of Respiratory Cell Biology

Imperial College London

UNITED KINGDOM

View details

Ian Pavord

Professor of Respiratory Medicine/Honorary Consultant Physician

University of Oxford

UNITED KINGDOM

View details

ALBERTO PAPI

Full Professor of Respiratory Medicine, Head Respiratory Medicine

University of Ferrara

ITALY

View details

Jennifer Quint

Professor of Respiratory Epidemiology

Imperial College London

UNITED KINGDOM

View details

Timothy Hinks

Associate Professor

University of Oxford

UNITED KINGDOM

View details

Paola Rogliani

professore associato

Università degli Studi di Roma Tor Vergata Facoltà di Medicina e Chirurgia

ITALY

View details

Maria Deprez

King’s College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mona Bafadhel

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (27)

Rebranding COPD Care and Research in the 21st Century

Effect of Dupilumab on Health-Related Quality of Life and Respiratory Symptoms in Patients With COPD and Type 2 Inflammation

Effect of budesonide/glycopyrronium/formoterol fumarate dihydrate on cardiopulmonary outcomes in COPD: rationale and design of the THARROS trial

Type 2 inflammation biomarkers and their association with response to dupilumab in COPD (BOREAS): an analysis of a randomised, placebo-controlled, phase 3 trial.

Respiratory Clinicians’ Views on Offering “Rescue Packs” to Patients Discharged After COPD Exacerbation: Qualitative Interview Study

Longitudinal changes in cardiopulmonary outcomes of adults born extremely prematurely: United Kingdom Oscillation Study.

The Risk-Benefit Balance of Oral Corticosteroid Treatment for Asthma Attacks: A Discrete Choice Experiment of Patients and Healthcare Professionals in the UK and New Zealand.

Dupilumab reduces acute exacerbations and improves lung function in patients with COPD with type 2 inflammation irrespective of body mass index, airflow obstruction, dyspnea, and exercise capacity index scores

Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype

Step up to triple therapy versus switch to dual bronchodilator therapy in patients with COPD on an inhaled corticosteroid/long-acting β&lt;sub&gt;2&lt;/sub&gt;-agonist: post-hoc analyses of KRONOS.

Understanding evidence from randomised controlled trials and meta-analyses: a comparative overview

QRISK3 underestimates the risk of cardiovascular events in patients with COPD

ChatGPTversusBing: a clinician assessment of the accuracy of AI platforms when responding to COPD questions

Functional MRI Assessment of the Lungs in Fetuses that Deliver Very Preterm: an MRI pilot study.

Coordinated nasal mucosa-mediated immunity accelerates recovery from COVID-19

How have we measured trial outcomes of asthma attack treatment? A systematic review

Targeting Type 2 Inflammation and Epithelial Alarmins in Chronic Obstructive Pulmonary Disease: A Biologics Outlook

Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids While on Monoclonal Antibody Therapy: Protocol for a Prospective Observational Study (BOOST)

Temporal Release of IL-1 Family Members from Virally Infected Airway Epithelial Cells Suggests IL-36γ Is the Early Responder

Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2): a non-inferiority, multicentre, double-blind, placebo-controlled, randomised controlled trial.

Inhaled corticosteroids for the treatment of COVID-19

Performance of cough monitoring by Albus Home, a contactless and automated system for nocturnal respiratory monitoring at home

Performance of Contactless Respiratory Rate Monitoring by Albus HomeTM, an Automated System for Nocturnal Monitoring at Home: A Validation Study

Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS

Moving the pathway goalposts

Towards the elimination of chronic obstructive pulmonary disease

Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids

Collaborators (20)

John Hurst

Joan B Soriano

Klaus F. Rabe

Richard Beasley

Imran Satia

Anne Greenough

Rocio Teresa Martinez-Nunez

Sanjay Ramakrishnan

Charlotte Bolton

Camille Taillé

James Melhorn

RICHARD RUSSELL

Kelly Payette

Louise Donnelly

Ian Pavord

ALBERTO PAPI

Jennifer Quint

Timothy Hinks

Paola Rogliani

Maria Deprez

Make your next move.

Step up to triple therapy versus switch to dual bronchodilator therapy in patients with COPD on an inhaled corticosteroid/long-acting β<sub>2</sub>-agonist: post-hoc analyses of KRONOS.